Standout Papers

Intra-arterial Prourokinase for Acute Ischemic Stroke 1995 2026 2005 2015 2.2k
  1. Intra-arterial Prourokinase for Acute Ischemic Stroke (1999)
    Anthony J. Furlan, Randall T. Higashida et al. JAMA
  2. Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (2003)
    Agnes Lee, Mark N. Levine et al. New England Journal of Medicine
  3. Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin (1995)
    Theodore E. Warkentin, Mark N. Levine et al. New England Journal of Medicine
  4. Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer (2000)
    Philip S. Wells, David R. Anderson et al. Thrombosis and Haemostasis
  5. Canadian Implantable Defibrillator Study (CIDS) (2000)
    Stuart J. Connolly, Michael Gent et al. Circulation
  6. PROACT: A Phase II Randomized Trial of Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute Middle Cerebral Artery Stroke (1998)
    Gregory J. del Zoppo, Randall T. Higashida et al. Stroke
  7. Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction (2004)
    Stefan H. Hohnloser, Karl Heinz Kuck et al. New England Journal of Medicine
  8. A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis (1996)
    Mark Levine, Michael Gent et al. New England Journal of Medicine
  9. Canadian atrial fibrillation anticoaguiation (CAFA) study (1991)
    Stuart J. Connolly, Andreas Laupacis et al. Journal of the American College of Cardiology
  10. Aspirin, Sulfinpyrazone, or Both in Unstable Angina (1985)
    John A. Cairns, Michael Gent et al. New England Journal of Medicine
  11. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial (2009)
    Alexander GG Turpie, Michael R. Lassen et al. The Lancet
  12. Platelet-Active Drugs (2001)
    Carlo Patrono, Barry S. Coller et al. CHEST Journal
  13. THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE (1989)
    Michael Gent, J. Donald Easton et al. The Lancet
  14. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT (1997)
    John A. Cairns, Stuart J. Connolly et al. The Lancet
  15. A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome (2003)
    Mark Crowther, Jeff Ginsberg et al. New England Journal of Medicine
  16. Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein Thrombosis (1986)
    Russell D. Hull, Gary E. Raskob et al. New England Journal of Medicine
  17. Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis (1982)
    R. Hull, J. Hirsh et al. New England Journal of Medicine
  18. Incidence of Recurrent Thromboembolic and Bleeding Complications Among Patients With Venous Thromboembolism in Relation to Both Malignancy and Achieved International Normalized Ratio: A Retrospective Analysis (2000)
    Barbara A. Hutten, Martin H. Prins et al. Journal of Clinical Oncology
  19. Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism (2003)
    Clive Kearon, Jeffrey S. Ginsberg et al. New England Journal of Medicine
  20. Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis (1979)
    Russell D. Hull, Terry Delmore et al. New England Journal of Medicine
  21. Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset (1984)
    C. R. Stiller, John Dupré et al. Science
  22. Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis (1982)
    Russell D. Hull, Terry Delmore et al. New England Journal of Medicine
  23. The Burlington Randomized Trial of the Nurse Practitioner (1974)
    Walter O. Spitzer, David L. Sackett et al. New England Journal of Medicine

Immediate Impact

5 from Science/Nature 94 standout
Sub-graph 1 of 18

Citing Papers

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
11 intermediate papers

Works of Michael Gent being referenced

Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein Thrombosis
1986 Standout
and 14 more

Author Peers

Author Last Decade Papers Cites
Michael Gent 20314 16802 9176 229 35.3k
Mark Crowther 19077 20658 9917 573 38.6k
Menno V. Huisman 15073 19427 5605 461 28.6k
Sam Schulman 21025 20968 6907 494 33.5k
Jack Hirsh 22531 22053 13188 345 37.9k
Harry R. Büller 19612 25437 8660 454 36.4k
Martin H. Prins 17339 19486 8610 381 33.8k
John A. Heit 14795 22992 9054 214 30.0k
Samuel Z. Goldhaber 26864 33904 10306 598 45.9k
John W. Eikelboom 34233 18050 9081 653 46.1k
Mark N. Levine 8778 12063 6569 317 30.6k

All Works

Loading papers...

Rankless by CCL
2026